Flamingo Therapeutics

Flamingo Therapeutics

www.flamingotx.com

hello@flamingotx.com

+32 16 85 26 41

Gaston Geenslaan 3 BLDG 4

3001 Leuven

BE

Flamingo Therapeutics

Foundation date

04/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    15 hours ago

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

Jobs by Flamingo Therapeutics

More info?

Contact us

Ellen Telleir

Communication Coordinator